RISKS FOR SUDDEN CARDIAC (SCD) AND UNDETERMINED CAUSE OF DEATH (UDD) AMONG PEOPLE WITH HIV (PWH) IN THE REPRIEVE PRIMARY CARDIOVASCULAR PREVENTION TRIAL
Aya Awwad(Harvard University), Steven Grinspoon(Massachusetts General Hospital), Carl J. Fichtenbaum(Cancer Research And Biostatistics), Sophia Zhao(Austin Health), Kayla Paradis(Cancer Research And Biostatistics), Pamela S. Douglas(Duke University), Michael T. Lu(Cancer Research And Biostatistics), Sarah Chu(MGH Institute of Health Professions), Markella V. Zanni(Harvard University), Isabelle R. Weir(Cancer Research And Biostatistics), Carlos Malvestutto(The Ohio State University Wexner Medical Center), Gerald S. Bloomfield, Marissa R Diggs(Harvard University), Judith S. Currier(University of California, Los Angeles), Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Stephen D. Wiviott(Thrombolysis in Myocardial Infarction Study Group), Christopher R. deFilippi, Heather J. Ribaudo(Cancer Research And Biostatistics)
Cited by 0
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
|New England Journal of Medicine|2017|6k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k